Genome-wide transcriptomics identifies an early preclinical signature of prion infection
Open accessPublished version of a preprint
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The clinical course of prion diseases is accurately predictable despite long latency periods, suggesting that prion pathogenesis is driven by precisely timed molecular events. We constructed a searchable genome-wide atlas of mRNA abundance, splicing and editing alterations during the course of disease in prion-inoculated mice. Prion infection induced transient changes in mRNA abundance and processing already at eight weeks post inoculation, well ahead of any neuropathological and clinical signs. In contrast, microglia-enriched genes displayed an increase simultaneous with the appearance of clinical symptoms, whereas neuronal-enriched transcripts remained unchanged until the very terminal stage of disease. This suggests that glial pathophysiology, rather than neuronal demise, represents the final driver of disease. The administration of young plasma attenuated the occurrence of early mRNA abundance alterations and delayed symptoms in the terminal phase of the disease. The early onset of prion-induced molecular changes might thus point to novel biomarkers and potential interventional targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Men and mice: Relating their ages
Dutta, S., & Sengupta, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2015.10.025 · Cited by 1,710
Detecting differential usage of exons from RNA-seq data
Anders, S., Reyes, A., & Huber, W. (2012) · Genome Research · doi:10.1101/gr.133744.111 · Cited by 1,545
Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice
Villeda, S. A., Plambeck, K. E., Middeldorp, J., Castellano, J. M., Mosher, K. I., Luo, J., Smith, L. K., Bieri, G., Lin, K., Berdnik, D., et al. (2014) · Nature Medicine · doi:10.1038/nm.3569 · Cited by 1,081
Kuru in the 21st century—an acquired human prion disease with very long incubation periods
Collinge, J., Whitfield, J., McKintosh, E., Beck, J., Mead, S., Thomas, D. J., & Alpers, M. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68930-7 · Cited by 474
Biology and Genetics of Prions Causing Neurodegeneration
Prusiner, S. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155524 · Cited by 455
Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
Srinivasan, K., Friedman, B. A., Larson, J. L., Lauffer, B. E., Goldstein, L. D., Appling, L. L., Borneo, J., Poon, C., Ho, T., Cai, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms11295 · Cited by 336
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287
Preclinical Assessment of Young Blood Plasma for Alzheimer Disease
Middeldorp, J., Lehallier, B., Villeda, S. A., Miedema, S. S. M., Evans, E., Czirr, E., Zhang, H., Luo, J., Stan, T., Mosher, K. I., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3185 · Cited by 153
Synaptic distribution of the endocytic accessory proteins AP180 and CALM
Yao, P. J., Petralia, R. S., Bushlin, I., Wang, Y., & Furukawa, K. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20362 · Cited by 49
Research works printed but not linked: 31
- A Aguzzi, 2009, Prions: protein aggregation and infectious diseases, Physiol Rev, 89, 1105, 10.1152/physrev.00006.2009 · DOI · Paper page
- AJ Swerdlow, 2003, Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone, Neurology, 61, 783, 10.1212/01.WNL.0000084000.27403.15 · DOI · Paper page
- A Aguzzi, 2013, The immunobiology of prion diseases, Nat Rev Immunol, 13, 888, 10.1038/nri3553 · DOI
- J. Collinge, 2016, Mammalian prions and their wider relevance in neurodegenerative diseases, Nature, 539, 217, 10.1038/nature20415 · DOI · Paper page
- MK Sandberg, 2011, Prion propagation and toxicity in vivo occur in two distinct mechanistic phases, Nature, 470, 540, 10.1038/nature09768 · DOI · Paper page
- MK Sandberg, 2014, Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked, Nat Commun, 5, 4347, 10.1038/ncomms5347 · DOI · Paper page
- A Majer, 2012, Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice, PLoS Pathog, 8, e1003002, 10.1371/journal.ppat.1003002 · DOI · Paper page
- W Xiang, 2004, Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology, J Virol, 78, 11051, 10.1128/JVI.78.20.11051-11060.2004 · DOI · Paper page
- A Majer, 2019, The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease, Sci Rep, 9, 1099, 10.1038/s41598-018-37715-z · DOI
- E Kanata, 2019, RNA editing alterations define manifestation of prion diseases, Proc Natl Acad Sci U S A, 116, 19727, 10.1073/pnas.1803521116 · DOI
- A Aguzzi, 2018, Toward Therapy of Human Prion Diseases, Annu Rev Pharmacol Toxicol, 58, 331, 10.1146/annurev-pharmtox-010617-052745 · DOI
- JA Moreno, 2012, Sustained translational repression by eIF2α-P mediates prion neurodegeneration, Nature, 485, 507, 10.1038/nature11058 · DOI · Paper page
- K Anthony, 2010, Aberrant RNA processing events in neurological disorders, Brain Res, 1338, 67, 10.1016/j.brainres.2010.03.008 · DOI
- ML Klebig, 2003, Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice, Proc Natl Acad Sci U S A, 100, 8360, 10.1073/pnas.1432634100 · DOI · Paper page
- T Yamada, 1993, Neuron-specific splicing of the Alzheimer amyloid precursor protein gene in a mini-gene system, Biochem Biophys Res Commun, 195, 442, 10.1006/bbrc.1993.2063 · doi:10.1006/bbrc.1993.2063
- H Keren-Shaul, 2017, A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
- M. Singh, 2012, Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration, Front Genet, 3, 326
- A. Aguzzi, 2006, Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis, J Neurochem, 97, 1726, 10.1111/j.1471-4159.2006.03909.x · DOI
- H Keren-Shaul, 2017, A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
- L Iaccarino, 2018, An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease, Mol Neurobiol, 55, 2856, 10.1007/s12035-017-0522-6 · DOI
- EV Minikel, Prion protein lowering is a disease-modifying therapy across prion strains, disease stages, and endpoints, Neuroscience
- M Nuvolone, 2016, Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science, J Exp Med, 213, 313, 10.1084/jem.20151610 · DOI · Paper page
- S Sorce, 2014, The role of the NADPH oxidase NOX2 in prion pathogenesis, PLoS Pathog, 10, e1004531, 10.1371/journal.ppat.1004531 · DOI · Paper page
- M Pfammatter, 2017, Absolute Quantification of Amyloid Propagons by Digital Microfluidics, Anal Chem, 89, 12306, 10.1021/acs.analchem.7b03279 · DOI
- M Nuvolone, 2013, SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells, J Exp Med, 210, 2539, 10.1084/jem.20131274 · DOI · Paper page
- A Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinforma Oxf Engl, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
- MD Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinforma Oxf Engl, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- LD Goldstein, 2016, Prediction and Quantification of Splice Events from RNA-Seq Data, PloS One, 11, e0156132, 10.1371/journal.pone.0156132 · DOI · Paper page
- E Picardi, 2013, REDItools: high-throughput RNA editing detection made easy, Bioinforma Oxf Engl, 29, 1813, 10.1093/bioinformatics/btt287 · DOI · Paper page
- DC Koboldt, 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, 22, 568, 10.1101/gr.129684.111 · DOI · Paper page
- P Cingolani, 2012, A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3, Fly (Austin), 6, 80, 10.4161/fly.19695 · DOI · Paper page
Cited by
Scheckel, C., Imeri, M., Schwarz, P., & Aguzzi, A. (2020) · eLife · doi:10.7554/elife.62911 · Cited by 57
Self-citationA single-cell map of antisense oligonucleotide activity in the brain
Mortberg, M. A., Gentile, J. E., Nadaf, N. M., Vanderburg, C., Simmons, S., Dubinsky, D., Slamin, A., Maldonado, S., Petersen, C. L., Jones, N., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad371 · Cited by 54
Glial activation in prion diseases is selectively triggered by neuronal PrPSc
Lakkaraju, A. K. K., Sorce, S., Senatore, A., Nuvolone, M., Guo, J., Schwarz, P., Moos, R., Pelczar, P., & Aguzzi, A. (2022) · Brain Pathology · doi:10.1111/bpa.13056 · Cited by 34
Self-citationSlota, J. A., Medina, S. J., Frost, K. L., & Booth, S. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.918811 · Cited by 16
Loss of Homeostatic Microglia Signature in Prion Diseases
Wang, Y., Hartmann, K., Thies, E., Mohammadi, B., Altmeppen, H., Sepulveda-Falla, D., Glatzel, M., & Krasemann, S. (2022) · Cells · doi:10.3390/cells11192948 · Cited by 12
Metadata
- Authors
- Sorce, S., Nuvolone, M., Russo, G., Chincisan, A., Heinzer, D., Avar, M., Pfammatter, M., Schwarz, P., Delic, M., Müller, M., Hornemann, S., Sanoudou, D., Scheckel, C., & Aguzzi, A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-06-29
- Volume
- 16
- Issue
- 6
- Pages
- e1008653
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W3037812738
- Cited by
- 63
- References
- 11
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Update notices
- new_version (2020-07-14)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.